Literature DB >> 18574092

Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality.

Harald Dobnig1, Stefan Pilz, Hubert Scharnagl, Wilfried Renner, Ursula Seelhorst, Britta Wellnitz, Jürgen Kinkeldei, Bernhard O Boehm, Gisela Weihrauch, Winfried Maerz.   

Abstract

BACKGROUND: In cross-sectional studies, low serum levels of 25-hydroxyvitamin D are associated with higher prevalence of cardiovascular risk factors and disease. This study aimed to determine whether endogenous 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels are related to all-cause and cardiovascular mortality.
METHODS: Prospective cohort study of 3258 consecutive male and female patients (mean [SD] age, 62 [10] years) scheduled for coronary angiography at a single tertiary center. We formed quartiles according to 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels within each month of blood drawings. The main outcome measures were all-cause and cardiovascular deaths.
RESULTS: During a median follow-up period of 7.7 years, 737 patients (22.6%) died, including 463 deaths from cardiovascular causes. Multivariate-adjusted hazard ratios (HRs) for patients in the lower two 25-hydroxyvitamin D quartiles (median, 7.6 and 13.3 ng/mL [to convert 25-hydroxyvitamin D levels to nanomoles per liter, multiply by 2.496]) were higher for all-cause mortality (HR, 2.08; 95% confidence interval [CI], 1.60-2.70; and HR, 1.53; 95% CI, 1.17-2.01; respectively) and for cardiovascular mortality (HR, 2.22; 95% CI, 1.57-3.13; and HR, 1.82; 95% CI, 1.29-2.58; respectively) compared with patients in the highest 25-hydroxyvitamin D quartile (median, 28.4 ng/mL). Similar results were obtained for patients in the lowest 1,25-dihydroxyvitamin D quartile. These effects were independent of coronary artery disease, physical activity level, Charlson Comorbidity Index, variables of mineral metabolism, and New York Heart Association functional class. Low 25-hydroxyvitamin D levels were significantly correlated with variables of inflammation (C-reactive protein and interleukin 6 levels), oxidative burden (serum phospholipid and glutathione levels), and cell adhesion (vascular cell adhesion molecule 1 and intercellular adhesion molecule 1 levels).
CONCLUSIONS: Low 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels are independently associated with all-cause and cardiovascular mortality. A causal relationship has yet to be proved by intervention trials using vitamin D.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18574092     DOI: 10.1001/archinte.168.12.1340

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  389 in total

1.  Increased vitamin D is associated with decline of naïve, but accumulation of effector, CD8 T cells during early aging.

Authors:  Yong Gil Hwang; Hui-Chen Hsu; Fei-Chu Lim; Qi Wu; PingAr Yang; Gordon Fisher; Gary R Hunter; John D Mountz
Journal:  Adv Aging Res       Date:  2013-05

2.  Impaired cardiac autonomic functions in apparently healthy subjects with vitamin D deficiency.

Authors:  Uğur Canpolat; Fırat Özcan; Özcan Özeke; Osman Turak; Çağr Yayla; Sadık Kadri Açıkgöz; Serkan Çay; Serkan Topaloğlu; Dursun Aras; Sinan Aydoğdu
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-11-02       Impact factor: 1.468

3.  Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats.

Authors:  Robyn Balden; Amutha Selvamani; Farida Sohrabji
Journal:  Endocrinology       Date:  2012-03-09       Impact factor: 4.736

4.  25- hydroxyvitamin d: explosion in clinical interest and laboratory requests.

Authors:  Waad-Allah Mula-Abed
Journal:  Oman Med J       Date:  2009-10

Review 5.  Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes.

Authors:  Asma Arabi; Rola El Rassi; Ghada El-Hajj Fuleihan
Journal:  Nat Rev Endocrinol       Date:  2010-10       Impact factor: 43.330

6.  Associations among 25-hydroxyvitamin D, diet quality, and metabolic disturbance differ by adiposity in adults in the United States.

Authors:  M A Beydoun; A Boueiz; M R Shroff; H A Beydoun; Y Wang; A B Zonderman
Journal:  J Clin Endocrinol Metab       Date:  2010-05-12       Impact factor: 5.958

7.  Heritability and seasonal variability of vitamin D concentrations in male twins.

Authors:  Cristina Karohl; Shaoyong Su; Meena Kumari; Vin Tangpricha; Emir Veledar; Viola Vaccarino; Paolo Raggi
Journal:  Am J Clin Nutr       Date:  2010-10-13       Impact factor: 7.045

8.  Association between serum 25-hydroxyvitamin D level and subclinical cardiovascular disease in primary hyperparathyroidism.

Authors:  Marcella D Walker; Elaine Cong; Anna Kepley; Marco R Di Tullio; Tatjana Rundek; Shunichi Homma; James A Lee; Rui Liu; Polly Young; Chiyuan Zhang; Donald J McMahon; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2013-11-27       Impact factor: 5.958

9.  Vitamin D deficiency and degree of coronary artery luminal stenosis in women undergoing coronary angiography: a prospective observational study.

Authors:  Chris Morgan; Andreas Kyvernitakis; Roy Cho; Orestis Pappas; Karthikeyan Ranganathan; Michael R Fischer; Venkatraman Srinivasan
Journal:  Am J Cardiovasc Dis       Date:  2018-04-05

10.  Fish consumption, sleep, daily functioning, and heart rate variability.

Authors:  Anita L Hansen; Lisbeth Dahl; Gina Olson; David Thornton; Ingvild E Graff; Livar Frøyland; Julian F Thayer; Staale Pallesen
Journal:  J Clin Sleep Med       Date:  2014-05-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.